"with only a 30% success rate in companies passing phase 2 trials"
I believe the figure of 30% is for all trials - the success rate for trials using topical application are not separated out and can be expected to be higher than 30%.
Further, BOT has at least three products in the pipeline and, IMO, another potential mystery product, so when one does one's sums 8.1 cents appears farcical.
I just watch the strange antics with glazed detachment and cynicism.
"with only a 30% success rate in companies passing phase 2...
-
- There are more pages in this discussion • 126 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.010(2.82%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.0¢ | 34.5¢ | $424.9K | 1.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 254414 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 53441 | 6 |
View Market Depth
| Last trade - 12.39pm 27/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
